<DOC>
	<DOCNO>NCT02710487</DOCNO>
	<brief_summary>Sleep benefit ( SB ) prominent spontaneous , apparently unpredictable , transitory improvement motor function report around 50 % patient affect Parkinson 's Disease ( PD ) sleep take first dose dopaminergic medication . The aim study test hypothesis objective and/or subjective improvement motor function might due carry-over effect Rapid Eye Movements ( REM ) sleep awaken sleep phase .</brief_summary>
	<brief_title>Sleep , Awake &amp; Move - Part II</brief_title>
	<detailed_description>The `` Awake &amp; Move '' study second part Sleep , Awake &amp; Move project . This study conduct subgroup unselected , consecutive patient complete part I Sleep , Awake &amp; Move project ( i.e . `` Sleep &amp; Move '' study ) . The investigator plan explore carry-over effect REM sleep motor function subgroup PD subject p. In interventional study investigator expect induce SB awaken subject nocturnal REM sleep sleep laboratory setting , Non-Rapid Eye Movements ( NREM ) sleep ( control intervention ) .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Diagnostic criterion idiopathic Parkinson 's disease ( UKPDBB ) Mild moderate disease ( Hoehn &amp; Yahr score ≥ 1 &lt; 3 ) Mentally physically capable give inform consent Stable antiparkinsonian psychotropic therapy last 30 day Atypical parkinsonian syndrome Cognitive impairment ( MMSE ≥ 26 ) Deep brain stimulation History cerebrovascular disease , epilepsy , disable neurological disease Psychiatric disorder , except mild depression Alcohol abuse Other clinically significant severe concomitant disease state Inability follow procedure study ( e.g . due language problem , psychological disorder , etc . ) Participation another study investigational drug within 60 day precede present project . subject ( ) sleepdisordered breathe [ Respiratory Disorder Index ( RDI ) ≥ 5 ] ( b ) clearcut distinction REM NREM sleep , base videopolysomongraphical recording .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Parkinson 's disease , Sleep Benefit</keyword>
</DOC>